RBC Life Sciences promotes Young
This article was originally published in The Tan Sheet
The multi-level marketer of nutritional, wound-care and pain-management products RBC Life Sciences promotes Kevin Young to the new post of sales and marketing VP. The move comes as the firm re-brands its nutritionals business and aims to grow North American sales. RBC said May 24 Young joined the Irving, Texas-based firm in 2008 as director of sales and has helped increase domestic sales by more than 25 percent
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”